Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
Janna Andrews, MD takes us for a tour of the latest technological advancements in the field of radiation therapy delivery for prostate cancer treatment. She explains the benefits…
NEW YORK (Reuters Health) – The increased risk of breast cancer in women who received radiotherapy above the diaphragm for treatment of Hodgkin’s lymphoma (HL) persists for at…
When should patients seek a biopsy on their prostate? Under what circumstances is a biopsy administered? Stacy Loeb, MD, explains that the American Urological Association’s 2009 guidelines, the PSA,…
Low-risk prostate cancer patients have multiple options when it comes to treatment. Janna Andrews, MD, characterizes the differences between surgical and radiation treatments as well as the various subcategories…
Janna Andrews, MD, discusses the clinical threshold for when a physician should consider preforming a biopsy after preforming a PSA exam to screen for prostate cancer. She also…
How has the nature of chemotherapy and prostate cancer evolved? Janna Andrews, MD, explains that historically, there were not many options for patients who became resistant to androgen deprivation therapy…
How can physicians evaluate what rising PSA levels mean when screening for prostate cancer? Janna Andrews, MD, explains how PSA levels rise naturally with growing age, and how physicians can use…
The recent PLCO study and its results have sparked controversy in some circles. The trial concludes that routine PSA exams and digital rectal exams, standard screening exams for prostate cancer,…
NEW YORK (Reuters Health) – In a Korean study of patients with advanced non-small-cell lung cancer who had never smoked and were previously treated with platinum-based chemotherapy, progression-free…
NEW YORK (Reuters Health) – In a phase three study of elderly patients with newly diagnosed acute myeloid leukemia (AML), decitabine achieved a higher response rate, with a…
